跳至主要内容
临床试验/NCT00004306
NCT00004306已完成不适用

Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)

Office of Rare Diseases (ORD)1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 1999年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1

研究概览

简要总结

OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies.

II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.

详细描述

PROTOCOL OUTLINE: Participants undergo a comprehensive clinical and molecular evaluation. Studies include: neurologic evaluation, including magnetic resonance imaging and nerve conduction studies; ophthalmologic exam; audiologic exam, including auditory brain stem evoked response; DNA extraction from blood, skin and muscle; genotype phenotype correlation.

A neuropathologic evaluation is conducted postmortem, when possible.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
3 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Office of Rare Diseases (ORD)
申办方类型
Nih
责任方
Principal Investigator
主要研究者

Tetsuo Ashizawa

Professor and Chair, Department of Neurology, The University of Texas Medical Branch

Office of Rare Diseases (ORD)

研究点 (1)

Loading locations...

相似试验